Cargando…

Integrating Bulk and Single-Cell RNA Sequencing Reveals Heterogeneity, Tumor Microenvironment, and Immunotherapeutic Efficacy Based on Sialylation-Related Genes in Bladder Cancer

BACKGROUND: As known abnormal sialylation exerts crucial roles in the growth, metastasis, and immune evasion of cancers, but the molecular characteristics and roles in bladder cancer (BLCA) remain unclear. This study intends to establish BLCA risk stratification based on sialylation-related genes an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Zhiyong, Chen, Xiaorong, Zuo, Jieming, Fu, Shi, Wang, Jiansong, Wang, Haifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438438/ https://www.ncbi.nlm.nih.gov/pubmed/37600224 http://dx.doi.org/10.2147/JIR.S418433

Ejemplares similares

Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model
por: Tan, Zhiyong, et al.
Publicado: (2023)

Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancer
por: Tan, Zhiyong, et al.
Publicado: (2023)

A commentary on ‘Self-expanding metal ureteral stent for ureteral stricture: experience of a large-scale prospective study from a high-volume center–cross-sectional study’ (Int J Surg 2021; 95: 106161)
por: Tan, Zhiyong, et al.
Publicado: (2023)

HSPB8 is a Potential Prognostic Biomarker that Correlates With Immune Cell Infiltration in Bladder Cancer
por: Tan, Zhiyong, et al.
Publicado: (2022)

Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity
por: Liu, Senbo, et al.
Publicado: (2023)

Identification of Potential Biomarkers for Progression and Prognosis of Bladder Cancer by Comprehensive Bioinformatics Analysis
por: Tan, Zhiyong, et al.
Publicado: (2022)

A commentary on ‘systematic review and meta-analysis of randomized controlled trials of perioperative outcomes and prognosis of transurethral en-bloc resection versus conventional transurethral resection for nonmuscle-invasive bladder cancer’ (Int J Surg 2022; 104:106777)
por: Tan, Zhiyong, et al.
Publicado: (2023)

Immunotherapeutic strategies for bladder cancer
por: Chevalier, Mathieu F, et al.
Publicado: (2014)

Single-cell and bulk tissue sequencing unravels the heterogeneity of synovial microenvironment in arthrofibrosis
por: Chen, Xi, et al.
Publicado: (2023)

Immunogenic cell death mediation patterns reveal novel paradigm for characterizing the immune microenvironment and immunotherapeutic responses in bladder cancer
por: Fu, Jialei, et al.
Publicado: (2022)

Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy
por: Lima, L, et al.
Publicado: (2013)

Sialylation: A Cloak for Tumors to Trick the Immune System in the Microenvironment
por: Zhou, Xiaoman, et al.
Publicado: (2023)

Nanomedicines targeting activation of STING to reshape tumor immune microenvironment and enhance immunotherapeutic efficacy
por: Chen, Shanshan, et al.
Publicado: (2023)

A commentary on ‘Safety and effectiveness of minimally invasive adrenalectomy versus open adrenalectomy in patients with large adrenal tumors (≥5 cm): a meta-analysis and systematic review’
por: Tan, Zhiyong, et al.
Publicado: (2023)

Collaborating single-cell and bulk RNA sequencing for comprehensive characterization of the intratumor heterogeneity and prognostic model development for bladder cancer
por: Wang, Jie, et al.
Publicado: (2023)

Targeted Approaches to Inhibit Sialylation of Multiple Myeloma in the Bone Marrow Microenvironment
por: Natoni, Alessandro, et al.
Publicado: (2019)

Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents
por: Wang, Liang-Chuan S, et al.
Publicado: (2015)

Membrane glycomics reveal heterogeneity and quantitative distribution of cell surface sialylation
por: Park, Diane Dayoung, et al.
Publicado: (2018)

Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer
por: Chen, Jiang, et al.
Publicado: (2022)

Immunotherapeutic Implications of Toll-like Receptors Activation in Tumor Microenvironment
por: Zheng, Run, et al.
Publicado: (2022)

Tumor Immune Microenvironment Landscape in Glioma Identifies a Prognostic and Immunotherapeutic Signature
por: Zhang, Chunyu, et al.
Publicado: (2021)

Tumor Microenvironment-Mediated Immune Profiles Characterized by Distinct Survival Outcome and Immunotherapeutic Efficacy in Breast Cancer
por: Xu, Lijun, et al.
Publicado: (2022)

Ultrasound-targeted microbubble destruction remodels tumour microenvironment to improve immunotherapeutic effect
por: Liu, Senbo, et al.
Publicado: (2022)

From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
por: Fu, Yaojie, et al.
Publicado: (2019)

Bioresponsive and immunotherapeutic nanomaterials to remodel tumor microenvironment for enhanced immune checkpoint blockade
por: Fang, Tianxu, et al.
Publicado: (2023)

Expression of a tumor-associated gene, LASS2, in the human bladder carcinoma cell lines BIU-87, T24, EJ and EJ-M3
por: ZHAO, QINGHUA, et al.
Publicado: (2013)

Tumor Microenvironment Profiling Identifies Prognostic Signatures and Suggests Immunotherapeutic Benefits in Neuroblastoma
por: Feng, Chenzhao, et al.
Publicado: (2022)

Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies
por: Pombo Antunes, Ana Rita, et al.
Publicado: (2020)

CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment
por: Seyfrid, Mathieu, et al.
Publicado: (2022)

Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors
por: Sarantis, Panagiotis, et al.
Publicado: (2022)

The tumor microenvironment in gastrointestinal adenocarcinomas revealed a prognostic and immunotherapeutic biomarker
por: Zhang, Yong, et al.
Publicado: (2022)

Automated synthesis of sialylated oligosaccharides
por: Esposito, Davide, et al.
Publicado: (2012)

Identification of a novel metabolism-related gene signature associated with the survival of bladder cancer
por: Li, Xiaotao, et al.
Publicado: (2021)

Integrated analysis of single-cell RNA-seq and bulk RNA-seq unveils heterogeneity and establishes a novel signature for prognosis and tumor immune microenvironment in ovarian cancer
por: Wang, Zitao, et al.
Publicado: (2023)

Recreating heterogeneity of bladder cancer microenvironment to study its recurrences and progression
por: Bordeleau, François, et al.
Publicado: (2023)

Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers
por: Trinchera, Marco, et al.
Publicado: (2017)

Long Noncoding RNA HAGLROS Promotes the Malignant Progression of Bladder Cancer by Regulating the miR-330-5p/SPRR1B Axis
por: Xiao, Shiwei, et al.
Publicado: (2022)

Heterogeneity and individualized treatment of microenvironment in glioblastoma (Review)
por: Kang, Wei, et al.
Publicado: (2023)

Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Liang-Hao, et al.
Publicado: (2021)

Detailed bladder cancer immunoprofiling reveals new clues for immunotherapeutic strategies
por: Viveiros, Nicole, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_miku5ofeogu0ssk7tg0lr6nsqp